Cisco Stock: Why Wall Street Is Bullish After Earnings
Cisco stock is lower Thursday despite the tech giant's beat-and-raise quarter, but analysts aren't concerned. Here's what you need to know.

Cisco Systems (CSCO) stock is trading lower Thursday even after the networking equipment specialist beat top- and bottom-line expectations for its fiscal 2025 first quarter and raised its full-year outlook.
In the three months ended October 26, Cisco's revenue decreased 5.6% year over year to $13.8 billion, pressured by a 28% decline in its Networking segment to $6.8 billion. Its earnings per share (EPS) were down 18% from the year-ago period to 91 cents.
"Cisco is off to a strong start to fiscal 2025," said CEO Chuck Robbins in a statement. "Our customers are investing in critical infrastructure to prepare for artificial intelligence (AI), and with the breadth of our portfolio, we are uniquely positioned to capitalize on this opportunity."

Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
The results beat analysts' expectations. Wall Street was anticipating revenue of $13.77 billion and earnings of 87 cents per share, according to CNBC.
Since its Q1 results came in at the high end or above its guidance range, Cisco raised its outlook for the full fiscal year. The company now expects to achieve revenue in the range of $55.3 billion to $56.3 billion and earnings per share between $3.60 to $3.66. This compares to its previous forecast for revenue in the range of $55 billion to $56.2 billion and EPS of $3.52 to $3.58.
"We are focused on solid execution and operating discipline while making strategic investments to drive innovation and growth," said Cisco Chief Financial Officer Scott Herren.
Is Cisco stock a buy, sell or hold?
Cisco Systems is up 17% for the year to date on a total return basis (price change plus dividends) and Wall Street is moderately bullish on the blue chip stock.
According to S&P Global Market Intelligence, the average analyst target price for CSCO is $60.37, representing implied upside of roughly 5% to current levels. Meanwhile, the consensus recommendation is Buy.
Financial services firm Jefferies is one of those with a Buy rating on the Dow Jones stock. It also raised its price target on Cisco to $66 from $53 after earnings.
"Cisco reported solid results and guidance, bolstered by depleted customer inventory and positive AI commentary," wrote Jefferies analyst George Notter in a November 13 note. "Splunk was better than we expected. Order trends were strong – albeit on easy year-ago comparisons. Margins are looking good too as the company continues to manage costs tightly. We still think the risk/reward in the shares is tilted positively."
Related Content
Get Kiplinger Today newsletter — free
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more. Delivered daily. Enter your email in the box and click Sign Me Up.
Joey Solitro is a freelance financial journalist at Kiplinger with more than a decade of experience. A longtime equity analyst, Joey has covered a range of industries for media outlets including The Motley Fool, Seeking Alpha, Market Realist, and TipRanks. Joey holds a bachelor's degree in business administration.
-
M&A Is Why UnitedHealth Group Stock Is in of the 100,000% Return Club
UnitedHealth has given a master class in mergers and acquisitions over the years.
By Louis Navellier Published
-
How GLP-1 Drugs Could Revolutionize Retirement
GLP-1 drugs like Ozempic and Wegovy are already changing the way we age and manage chronic conditions.
By Jacob Schroeder Published
-
M&A Is Why UnitedHealth Group Stock Is in of the 100,000% Return Club
UnitedHealth has given a master class in mergers and acquisitions over the years.
By Louis Navellier Published
-
How to Invest in the Nuclear Revolution
According to Energy Secretary Chris Wright, "The long-awaited American nuclear renaissance must launch during President Trump's administration."
By David Dittman Published
-
How to Avoid These Five Costly Tax Mistakes That Many Retirees Make
Making incorrect assumptions about tax brackets, tax-loss harvesting, charitable giving, estate taxes and more can cost you big-time in retirement.
By Gaby C. Mechem Published
-
Are You a Baby Boomer With $500,000 or Less Saved for Retirement?
Here are seven ideas Baby Boomers can consider to help make the most of their financial resources for retirement.
By Cyrus Bamji Published
-
Social Security Fairness Act Adds to Pressure on Safety Net
While the law seeks to level the playing field for many federal employees, the sustainability of the Social Security system is now facing even more challenges.
By Brian Skrobonja, Chartered Financial Consultant (ChFC®) Published
-
Four Ways to Financially Embrace the Year of the Wood Snake
In the Year of the Wood Snake, consider looking to the snake's traits of being strategic, cunning and alert to help guide your finances this year.
By Marguerita M. Cheng, CFP® & RICP® Published
-
Stock Market Today: Dow Dives 748 Points as UnitedHealth Sells Off
A services-sector contraction and a worse-than-anticipated consumer sentiment reading sent bulls scrambling Friday.
By Karee Venema Published
-
Coinbase Stock Swings After SEC Drops Lawsuit
Coinbase stock is bouncing between positive and negative territory Friday on news the SEC is dismissing its lawsuit against the the crypto exchange.
By Joey Solitro Published